Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL341035 | 1.00 | — | — | |
| SCHEMBL1331666 | 0.94 | — | — | |
| SCHEMBL11026359 | 0.94 | — | — | |
| SCHEMBL298778 | 0.94 | — | — | |
| SCHEMBL1331921 | 0.94 | — | — | |
| SCHEMBL519 | 0.94 | — | — | |
| SCHEMBL5180151 | 0.94 | — | — | |
| SCHEMBL1331275 | 0.94 | — | — | |
| SCHEMBL4805130 | 0.89 | — | — | |
| Ethane SCHEMBL4306978 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 200 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109824539-B | Novel method for synthesizing tigecycline from demethyl aureomycin | 河北圣雪大成制药有限责任公司 | 2022-04-22 | — | — | CN | claimed |
| CN-103058878-B | 1, 3-allyl ethylene diamine tetraacetic acid as well as preparation method and application thereof | NIE SHIBAO | 2014-08-13 | — | — | CN | claimed |
| CN-103058878-A | 1, 3-allyl ethylene diamine tetraacetic acid as well as preparation method and application thereof | NIE SHIBAO | 2013-04-24 | — | — | CN | claimed |
| CN-102268022-A | Reference standard product for representing Cefroxadine and preparation method and application thereof | — | 2011-12-07 | — | — | CN | claimed |
| CN-1824658-B | Improvement preparation method of using 2-aminothiazole-4-acetyl chloride hydrochloride as intermediate of preparation cephalosporin | HAN MI PHARM IND CO LTD | 2011-10-05 | — | — | CN | claimed |
| CN-1824658-A | Improvement preparation method of using 2-aminothiazole-4-acetyl chloride hydrochloride as intermediate of preparation cephalosporin | HAN MI PHARM IND CO LTD (KR) | 2006-08-30 | — | — | CN | claimed |
| US-6251882-B1 | TREATING LEUKEMIA, BREAST CANCER, PROSTATE CANCER, OR BRAIN TUMOR | PARKER HUGHES INSTITUTE | 2001-06-26 | — | — | US | claimed |
| EP-1091934-A2 | ALKYL KETONES AS POTENT ANTI-CANCER AGENTS | Parker Hughes Institute (US) | 2001-04-18 | — | — | EP | claimed |
| WO-2000000469-A2 | ALKYL KETONES AS POTENT ANTI-CANCER AGENTS | PARKER HUGHES INSTITUTE (US) | 2000-01-06 | — | — | WO | claimed |
| EP-0587121-B1 | Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof | BRISTOL MYERS SQUIBB CO (US) | 1998-11-11 | — | — | EP | claimed |
| EP-0587121-A1 | Crystalline dihydrate of a cephalosporin dihydrochloride salt and injectable compositions thereof | Bristol-Myers Squibb Company (US) | 1994-03-16 | — | — | EP | claimed |
| JP-5339283-A | — | — | None | — | — | JP | disclosed |
| CN-221993108-U | Chloropropionyl chloride sampling device | 荆门市强生化工股份有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-111896742-B | Influenza efficacy test | 思齐乐 | 2024-08-06 | — | — | CN | disclosed |
| EP-4397770-A1 | STABILISATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS | PreAnalytiX GmbH (CH) | 2024-07-10 | — | — | EP | disclosed |
| JP-H05339283-A | 5-BROMO-4-CHLOROINDO-3-YL-2-SIALIC ACID | TANPAKU KOGAKU KENKYUSHO:KK | 1993-12-21 | — | — | JP | disclosed |
| CN-1067658-A | New cephalosporin compound | FUJISAWA PHARMACEUTICAL CO (JP) | 1993-01-06 | — | — | CN | disclosed |
| EP-0333082-A2 | Cephem compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1989-09-20 | — | — | EP | disclosed |
| CN-87106452-A | New cephalosporanic olefinic compound and preparation method thereof | — | 1988-05-04 | — | — | CN | disclosed |
| US-4298596-A | Trypanosoma cruzi glycoprotein vaccine for inducing immunity to Chagas' disease | BURROUGHS WELLCOME CO. (US) | 1981-11-03 | — | — | US | disclosed |